Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Rodrigues, Bruno ^a,b   Rosa, Kaleizu T ^b   Medeiros, Alessandra ^c   Schaan, Beatriz D ^d   Brum, Patricia C ^b   De Angelis, Kátia ^e   Irigoyen, Maria C ^b  

^a SÃO JUDAS TADEU UNIVERSITY   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e Nove de Julho University   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PHOSPHOLAMBAN; SERINE; STREPTOZOCIN; THREONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC DYSFUNCTION; CONTROLLED STUDY; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HYPERGLYCEMIA; MALE; MORTALITY; NONHUMAN; PRESSORECEPTOR REFLEX; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SODIUM CALCIUM EXCHANGE; STREPTOZOCIN DIABETES; WESTERN BLOTTING; ANIMAL; AUTONOMIC NEUROPATHY; DIABETES MELLITUS; EXPERIMENTAL DIABETES MELLITUS; HEART LEFT VENTRICLE FUNCTION; METABOLISM; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; HYPERGLYCEMIA; MALE; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79953645830     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-26     Document Type: Article

References (38)

1. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ 2001, 322:1389-1393. 10.1136/bmj.322.7299.1389, 32252, 11397742.
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234. 10.1056/NEJM199807233390404, 9673301.
3. Feuvray D, Lopaschuk GD. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res 1997, 34:113-120. 10.1016/S0008-6363(97)00037-0, 9217880.
4. Ravingerova T, Neckar J, Kolar F, Stetka R, Volkovova K, Ziegelhöffer A, Styk J. Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischaemia?. Basic Res Cardiol 2001, 96(2):160-168. 10.1007/s003950170066, 11327334.
5. Bäcklund T, Palojoki E, Saraste A, Eriksson A, Finckenberg P, Kytö V, Lakkisto P, Mervaala E, Voipio-Pulkki LM, Laine M, Tikkanen I. Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes. Diabetologia 2004, 47(2):325-330.
6. Liu Y, Thornton JD, Cohen MV, Downen JM, Schaffer SW. Streptozotocin-induced non-insulin dependent diabetes protect the heart from infarction. Circulation 1993, 88:1273-1278.
7. Ravingerova T, Stetka R, Volkovova K, Pancza D, Dzurba A, Ziegelhöffer A, Styk J. Acute diabetes modulates response to ischemia in isolated rat heart. Mol Cell Biochem 2000, 210:143-151. 10.1023/A:1007129708262, 10976767.
8. Chu LM, Osipov RM, Robich MP, Feng J, Oyamada S, Bianchi C, Sellke FW. Is hyperglycemia bad for the heart during acute ischemia?. J Thorac Cardiovasc Surg 2010, 140:1345-1352. 10.1016/j.jtcvs.2010.05.009, 20542299.
9. Malfitano C, Alba Loureiro TC, Rodrigues B, Sirvente R, Salemi VM, Rabechi NB, Lacchini S, Curi R, Irigoyen MC. Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell death. Eur J Heart Fail 2010, 12(7):659-667. 10.1093/eurjhf/hfq053, 20406798.
10. Schaffer SW, Croft CB, Solodushko V. Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis. Am J Physiol Heart Circ Physiol 2000, 278(6):H1948-54.
11. Periasamy M, Bhupathy P, Babu GJ. Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology. Cardiovasc Res 2008, 77(2):265-273. 10.1093/cvr/cvm056, 18006443.
12. Choi KM, Zhong Y, Hoit BD, Grupp IL, Hahn H, Dilly KW, Guatimosim S, Lederer WJ, Matlib MA. Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 2002, 283(4):H1398-H1408.
13. Jorge L, Rodrigues B, Rosa KT, Malfitano C, Loureiro TC, Medeiros A, Curi R, Brum PC, Lacchini S, Montano N, De Angelis K, Irigoyen MC. Cardiac and peripheral adjustments induced by early exercise training intervention were associated with autonomic improvement in infarcted rats: role in functional capacity and mortality. Eur Heart J
14. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010, 8(6):e1000412. 10.1371/journal.pbio.1000412, 2893951, 20613859.
15. Mostarda C, Rodrigues B, Vane M, Moreira ED, Rosa KT, Moraes-Silva IC, Lacchini S, Casarini DE, De Angelis K, Irigoyen MC. Autonomic impairment after myocardial infarction: role in cardiac remodelling and mortality. Clin Exp Pharmacol Physiol 2010, 37(4):447-452. 10.1111/j.1440-1681.2009.05327.x, 19878213.
16. Wichi R, Malfitano C, Rosa K, De Souza SB, Salemi V, Mostarda C, De Angelis K, Irigoyen MC. Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents. Cardiovasc Diabetol 2007, 26:6-14.
17. Medeiros A, Rolim NP, Oliveira RS, Rosa KT, Mattos KC, Casarini DE, Irigoyen MC, Krieger EM, Krieger JE, Negrão CE, Brum PC. Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice. J Appl Physiol 2008, 104(1):103-109. 10.1152/japplphysiol.00493.2007, 17975126.
18. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004, 141:421-431.
19. Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Probstfield JL, Simons-Morton DG, Friedewald WT. Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559. 10.1056/NEJMoa0802743, 18539917, Action to Control Cardiovascular Risk in Diabetes Study Group.
20. The ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572. 10.1056/NEJMoa0802987, 18539916, The ADVANCE Collaborative Group.
21. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD, . VADT Investigators Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360:129-139. 10.1056/NEJMoa0808431, 19092145, VADT Investigators.
22. Vogel WM, Apstein CS. Effects of alloxan-induced diabetes on ischemia-reperfusion injury in rabbit hearts. Circ Res 1988, 62(5):975-982.
23. Higuchi M, Ikema S, Sakanashi M. Correlation of contractile dysfunction and abnormal tissue energy metabolism during hypoperfusion with norepinephrine in isolated rat hearts: differences between normal and diabetic hearts. J Mol Cell Cardiol 1992, 24(10):1125-1141. 10.1016/0022-2828(92)93177-L, 1479614.
24. Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS, Eberli FR. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation 2000, 101(17):2090-2096.
25. King LM, Opie LH. Glucose and glycogen utilization in myocardial ischemia - changes in metabolism and consequences for the myocyte. Mol Cell Biochem 1998, 180(1-2):3-26. 10.1023/A:1006870419309, 9546626.
26. Ravingerova T, Neckar J, Kolar F. Ischemic tolerance of rat heart in acute and chronic phases of experimental diabetes. Mol Cell Biochem 2003, 249:167-174. 10.1023/A:1024751109196, 12956412.
27. Xu G, Takashi E, Kudo M, Ishiwata T, Naito Z. Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway. Exp Mol Pathol 2004, 76(1):57-65. 10.1016/j.yexmp.2003.08.003, 14738870.
28. de Tombe PP. Altered contractile function in heart failure. Cardiovasc Res 1998, 37:367-380. 10.1016/S0008-6363(97)00275-7, 9614494.
29. Mattiazzi A, Mundiña-Weilenmann C, Guoxiang C, Vittone L, Kranias E. Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions. Cardiovasc Res 2005, 68(3):366-375. 10.1016/j.cardiores.2005.08.010, 16226237.
30. Tosaki A, Engelman DT, Engelman RM, Das DK. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res 1996, 31(4):526-536.
31. Zorzano A, Sevilla L, Camps M, Becker C, Meyer J, Kammermeier H, Muñoz P, Gumà A, Testar X, Palacín M, Blasi J, Fischer Y. Regulation of glucose transport, and glucose transporters expression and trafficking in the heart: studies in cardiac myocytes. Am J Cardiol 1997, 80(3A):65A-76A. 10.1016/S0002-9149(97)00459-1, 9293957.
32. Belke DD, Larsen TS, Gibbs EM, Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol: Endocrinol Metab 2000, 279(5):E1104-E1113.
33. DaTorre SD, Creer MH, Pogwizd SM, Corr PB. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol 1991, 23(Suppl 1):11-22. 10.1016/0022-2828(91)90019-I, 2038071.
34. van den Brom CE, Huisman MC, Vlasblom R, Boontje NM, Duijst S, Lubberink M, Molthoff CF, Lammertsma AA, van der Velden J, Boer C, Ouwens DM, Diamant M. Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc Diabetol 2009, 22:8:39.
35. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003, 26(6):1895-1901. 10.2337/diacare.26.6.1895, 12766130.
36. Mostarda C, Rogow A, Silva IC, De La Fuente RN, Jorge L, Rodrigues B, Heeren MV, Caldini EG, De Angelis K, Irigoyen MC. Benefits of exercise training in diabetic rats persist after three weeks of detraining. Auton Neurosci 2009, 145(1-2):11-16. 10.1016/j.autneu.2008.10.010, 19022707.
37. Dall'ago P, D'Agord Schaan B, da Silva VO, Werner J, da Silva Soares PP, de Angelis K, Irigoyen MC. Parasympathetic dysfunction is associated with baroreflex and chemoreflex impairment in streptozotocin-induced diabetes in rats. Auton Neurosci 2007, 131(1-2):28-35.
38. Shyu JF, Wang HS, Shyr YM, Wang SE, Chen CH, Tan JS, Lin MF, Hsieh PS, Sytwu HK, Chen TH. Alleviation of hyperglycemia in diabetic rats by intraportal injection of insulin-producing cells generated from surgically resected human pancreatic tissue. J Endocrinol 2011, 208(3):233-244.